Terms: = Gastric cancer AND AFP, AFPD, FETA, HPAFP
501 results:
1. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
2. The inflammation score predicts the prognosis of gastric cancer patients undergoing Da Vinci robot surgery.
Chen X; Zhang Y; Liu Z; Song J; Li J
J Robot Surg; 2024 Mar; 18(1):131. PubMed ID: 38498240
[TBL] [Abstract] [Full Text] [Related]
3. Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients.
Zhang J; Wang L; Zhang S; Cao R; Zhao Y; Zhao Y; Song Y; Guo Z
BMC Cancer; 2024 Feb; 24(1):266. PubMed ID: 38408930
[TBL] [Abstract] [Full Text] [Related]
4. CircUSP1 as a novel marker promotes gastric cancer progression via stabilizing HuR to upregulate USP1 and Vimentin.
Li R; Wang J; Xie Z; Tian X; Hou J; Wang D; Qian H; Shen H; Xu W
Oncogene; 2024 Mar; 43(14):1033-1049. PubMed ID: 38366146
[TBL] [Abstract] [Full Text] [Related]
5. [A Case of Juvenile afp-Producing gastric cancer with Virchow Lymph Node Metastasis Achieved Long-Term Survival with Multimodal Therapy].
Ono HA; Suwa H; Minami Y; Nojiri K; Yoshida K; Masui H; Nagahori K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1892-1894. PubMed ID: 38303243
[TBL] [Abstract] [Full Text] [Related]
6. Prediction Model of Ocular Metastases in gastric Adenocarcinoma: Machine Learning-Based Development and Interpretation Study.
Zou J; Shen YK; Wu SN; Wei H; Li QJ; Xu SH; Ling Q; Kang M; Liu ZL; Huang H; Chen X; Wang YX; Liao XL; Tan G; Shao Y
Technol Cancer Res Treat; 2024; 23():15330338231219352. PubMed ID: 38233736
[No Abstract] [Full Text] [Related]
7. Alpha-fetoprotein-producing gastric cancer with ruptured liver metastasis mimicking hepatocellular carcinoma.
Kimura M; Matsuoka R; Nishikawa K; Imamura J; Kimura K
Clin J Gastroenterol; 2024 Apr; 17(2):234-239. PubMed ID: 38214832
[TBL] [Abstract] [Full Text] [Related]
8. [Clinicopathological features of gastric alpha-fetoprotein-producing adenocarcinoma with SWI/SNF complex deletion].
Yang JZ; Guo XX; Xu C; Hou YY; Yuan W
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):52-57. PubMed ID: 38178747
[No Abstract] [Full Text] [Related]
9. Analysis and Prediction of Significant Genes in gastric cancer Based on TCGA Database.
Li R; Lu Y; Yi Z; An J
Stud Health Technol Inform; 2023 Nov; 308():445-454. PubMed ID: 38007771
[TBL] [Abstract] [Full Text] [Related]
10. Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases.
Yang X; Wu Y; Wang A; Ma X; Zhou K; Ji K; Ji X; Zhang J; Wu X; Li Z; Bu Z
J Pathol Clin Res; 2024 Jan; 10(1):e343. PubMed ID: 37974386
[TBL] [Abstract] [Full Text] [Related]
11. A sensitive and robust plasma-based DNA methylation panel for early detection of target gastrointestinal cancers.
Dai Y; Li H; Wu Q; Wang J; Wang K; Fei S; Pei B; Song L; Chen G; Ma Y; Xia C; Xiong S; Zheng M; Xue Y; Zhao G; Xu H
Neoplasia; 2023 Dec; 46():100941. PubMed ID: 37918207
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of Clinicopathological Features and Prognosis of Mucinous gastric Carcinoma and other gastric cancers: A Retrospective Study of 4,417 Patients.
Ma Y; Zhang S; Wang Y; Hu C; Chen J; Pang C; Liang C; Yuan L; Du Y
J Gastrointest Surg; 2023 Nov; 27(11):2352-2364. PubMed ID: 37848685
[TBL] [Abstract] [Full Text] [Related]
13. A practical recurrence risk model based on Lasso-Cox regression for gastric cancer.
Huang B; Ding F; Li Y
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15845-15854. PubMed ID: 37672074
[TBL] [Abstract] [Full Text] [Related]
14. Radiomics-guided prognostic assessment of early-stage hepatocellular carcinoma recurrence post-radical resection.
Xie Q; Zhao Z; Yang Y; Long D; Luo C
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14983-14996. PubMed ID: 37606762
[TBL] [Abstract] [Full Text] [Related]
15. An autopsy case of alpha-fetoprotein-producing large duodenal adenocarcinoma.
Hirota S; Naganuma A; Kobayashi R; Suzuki Y; Hoshino T; Yasuoka H; Tanaka Y; Uraoka T; Kakizaki S
Clin J Gastroenterol; 2023 Dec; 16(6):829-835. PubMed ID: 37594614
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression.
Abe D; Akazawa Y; Yatagai N; Hayashi T; Ueyama H; Mine S; Fukunaga T; Nagahara A; Yao T; Saito T
Virchows Arch; 2023 Sep; 483(3):405-414. PubMed ID: 37581693
[TBL] [Abstract] [Full Text] [Related]
17. [A Patient with afp-Producing gastric cancer and Stenosis Who Regained Oral Intake Capabilities after T-DXd Treatment].
Amagai H; Sasagawa S; Koide Y; Tsukamoto S; Miyazawa Y; Yamakawa H; Murayama H; Sentsui T; Matsubara H; Yamazaki K; Yarita T
Gan To Kagaku Ryoho; 2023 Jul; 50(7):813-816. PubMed ID: 37496227
[TBL] [Abstract] [Full Text] [Related]
18. [Liver metastasis from alpha-fetoprotein-producing gastric cancer 27 years postoperation:a case report].
Nakamura H; Takanashi K; Morita R; Sakurada A; Hirata Y; Komatsu Y; Osanai M; Katsuki S
Nihon Shokakibyo Gakkai Zasshi; 2023; 120(7):602-609. PubMed ID: 37423731
[TBL] [Abstract] [Full Text] [Related]
19. Ribosomal DNA copy number alteration in blood sample from gastric cancer patients.
Chen C; Feng L; Chen J; Shen J; Lin L
Mol Biol Rep; 2023 Sep; 50(9):7155-7160. PubMed ID: 37407803
[TBL] [Abstract] [Full Text] [Related]
20. Exploring the molecular characteristics of the malignant potential of gastric adenocarcinoma with enteroblastic differentiation.
Wang Y; Wei X; Ke B; Liu J; Guo Y; Liu Y; Chen Y; Ding T; Wang Y; Meng B; Sun B; Zang F
Histopathology; 2023 Oct; 83(4):631-646. PubMed ID: 37356975
[TBL] [Abstract] [Full Text] [Related]
[Next]
